206 related articles for article (PubMed ID: 3141284)
41. Implication of neutral polysaccharides associated to alginate in inhibition of murine macrophage response to Pseudomonas aeruginosa.
Pasquier C; Marty N; Dournes JL; Chabanon G; Pipy B
FEMS Microbiol Lett; 1997 Feb; 147(2):195-202. PubMed ID: 9119193
[TBL] [Abstract][Full Text] [Related]
42. Surfactant protein D stimulates phagocytosis of Pseudomonas aeruginosa by alveolar macrophages.
Restrepo CI; Dong Q; Savov J; Mariencheck WI; Wright JR
Am J Respir Cell Mol Biol; 1999 Nov; 21(5):576-85. PubMed ID: 10536117
[TBL] [Abstract][Full Text] [Related]
43. Mechanism of resistance to phagocytosis and pulmonary persistence in mucoid
Rowe WJ; Lebman DA; Ohman DE
Front Cell Infect Microbiol; 2023; 13():1125901. PubMed ID: 37009499
[TBL] [Abstract][Full Text] [Related]
44. Phagocytosis and intracellular killing of Pseudomonas aeruginosa by peritoneal macrophages of mice.
Maresz-Babczyszyn J; Czarny A; Lagowska-Złotorzycka M
Arch Immunol Ther Exp (Warsz); 1984; 32(4):481-7. PubMed ID: 6442853
[TBL] [Abstract][Full Text] [Related]
45. Mucoid-to-nonmucoid conversion in alginate-producing Pseudomonas aeruginosa often results from spontaneous mutations in algT, encoding a putative alternate sigma factor, and shows evidence for autoregulation.
DeVries CA; Ohman DE
J Bacteriol; 1994 Nov; 176(21):6677-87. PubMed ID: 7961421
[TBL] [Abstract][Full Text] [Related]
46. Evaluation of polyvalent anti-Pseudomonas aeruginosa vaccine in phagocytic reaction.
Grzybek-Hryncewicz K; Gościniak G
Arch Immunol Ther Exp (Warsz); 1990; 38(3-4):291-7. PubMed ID: 2129384
[TBL] [Abstract][Full Text] [Related]
47. [Phagocytosis of Staphylococcus aureus and Pseudomonas aeruginosa by pulmonary macrophages and granulocytes].
Hürter T
Pneumologie; 1989 Mar; 43(3):147-58. PubMed ID: 2496407
[TBL] [Abstract][Full Text] [Related]
48. Studies on phagocytosis of mucoid and nonmucoid variants of Pseudomonas aeruginosa. I. Induction of homologous immunity by nonmucoid strains of P. aeruginosa.
Gościniak G; Grzybek-Hryncewicz K
Arch Immunol Ther Exp (Warsz); 1988; 36(2):177-84. PubMed ID: 2467637
[TBL] [Abstract][Full Text] [Related]
49. Opsonophagocytic killing antibody to Pseudomonas aeruginosa mucoid exopolysaccharide in older noncolonized patients with cystic fibrosis.
Pier GB; Saunders JM; Ames P; Edwards MS; Auerbach H; Goldfarb J; Speert DP; Hurwitch S
N Engl J Med; 1987 Sep; 317(13):793-8. PubMed ID: 2957591
[TBL] [Abstract][Full Text] [Related]
50. Opsonophagocytic killing activity of rabbit antibody to Pseudomonas aeruginosa mucoid exopolysaccharide.
Ames P; DesJardins D; Pier GB
Infect Immun; 1985 Aug; 49(2):281-5. PubMed ID: 3160660
[TBL] [Abstract][Full Text] [Related]
51. Mucoid Pseudomonas aeruginosa growing in a biofilm in vitro are killed by opsonic antibodies to the mucoid exopolysaccharide capsule but not by antibodies produced during chronic lung infection in cystic fibrosis patients.
Meluleni GJ; Grout M; Evans DJ; Pier GB
J Immunol; 1995 Aug; 155(4):2029-38. PubMed ID: 7636254
[TBL] [Abstract][Full Text] [Related]
52. Functional characterization of macrophage receptors for in vitro phagocytosis of unopsonized Pseudomonas aeruginosa.
Speert DP; Wright SD; Silverstein SC; Mah B
J Clin Invest; 1988 Sep; 82(3):872-9. PubMed ID: 3138287
[TBL] [Abstract][Full Text] [Related]
53. Role of alginate in infection with mucoid Pseudomonas aeruginosa in cystic fibrosis.
Pedersen SS; Høiby N; Espersen F; Koch C
Thorax; 1992 Jan; 47(1):6-13. PubMed ID: 1539148
[TBL] [Abstract][Full Text] [Related]
54. The effect of alginate on the invasion of cystic fibrosis respiratory epithelial cells by clinical isolates of Pseudomonas aeruginosa.
Massengale AR; Quinn FJ; Williams A; Gallagher S; Aronoff SC
Exp Lung Res; 2000; 26(3):163-78. PubMed ID: 10813089
[TBL] [Abstract][Full Text] [Related]
55. Induction of opsonic antibodies to Pseudomonas aeruginosa mucoid exopolysaccharide by an anti-idiotypic monoclonal antibody.
Schreiber JR; Pier GB; Grout M; Nixon K; Patawaran M
J Infect Dis; 1991 Sep; 164(3):507-14. PubMed ID: 1831226
[TBL] [Abstract][Full Text] [Related]
56. Selective down-regulation of alveolar macrophage oxidative response to opsonin-independent phagocytosis.
Kobzik L; Godleski JJ; Brain JD
J Immunol; 1990 Jun; 144(11):4312-9. PubMed ID: 2160498
[TBL] [Abstract][Full Text] [Related]
57. Effects of alginase on the natural history and antibiotic therapy of experimental endocarditis caused by mucoid Pseudomonas aeruginosa.
Bayer AS; Park S; Ramos MC; Nast CC; Eftekhar F; Schiller NL
Infect Immun; 1992 Oct; 60(10):3979-85. PubMed ID: 1398909
[TBL] [Abstract][Full Text] [Related]
58. RpmA is required for nonopsonic phagocytosis of Pseudomonas aeruginosa.
Simpson DA; Speert DP
Infect Immun; 2000 May; 68(5):2493-502. PubMed ID: 10768936
[TBL] [Abstract][Full Text] [Related]
59. Pseudomonas aeruginosa Regulated Intramembrane Proteolysis: Protease MucP Can Overcome Mutations in the AlgO Periplasmic Protease To Restore Alginate Production in Nonmucoid Revertants.
Delgado C; Florez L; Lollett I; Lopez C; Kangeyan S; Kumari H; Stylianou M; Smiddy RJ; Schneper L; Sautter RT; Smith D; Szatmari G; Mathee K
J Bacteriol; 2018 Aug; 200(16):. PubMed ID: 29784885
[TBL] [Abstract][Full Text] [Related]
60. Specificity of opsonic antibodies to enhance phagocytosis of Pseudomonas aeruginosa by human alveolar macrophages.
Reynolds HY; Kazmierowski JA; Newball HH
J Clin Invest; 1975 Aug; 56(2):376-85. PubMed ID: 807599
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
